Vaccinex, Inc. Available-for-sale Securities, Amortized Cost Basis
Vaccinex, Inc. (VCNX) had Available-for-sale Securities, Amortized Cost Basis of $16.12 million as of 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2018-11-13
- 2018-09-30: Available-for-sale Securities, Amortized Cost Basis $16.12M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2018-09-30 | $16.12M 10-Q · filed 2018-11-13 |